These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16613922)

  • 1. Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice.
    Fukushima A; Yamaguchi T; Azuma M; Yagita H; Ueno H
    Br J Ophthalmol; 2006 Aug; 90(8):1040-5. PubMed ID: 16613922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch ligand Delta-like4 inhibits the development of murine experimental allergic conjunctivitis.
    Fukushima A; Sumi T; Ishida W; Ojima A; Kajisako M; Koyanagi A; Koyama N; Yagita H
    Immunol Lett; 2008 Dec; 121(2):140-7. PubMed ID: 19027794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD27 and CD70 do not play a critical role in the development of experimental allergic conjunctivitis in mice.
    Sumi T; Ishida W; Ojima A; Kajisako M; Sakanishi T; Yagita H; Fukushima A
    Immunol Lett; 2008 Aug; 119(1-2):91-6. PubMed ID: 18579220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 10 and transforming growth factor beta contribute to the development of experimentally induced allergic conjunctivitis in mice during the effector phase.
    Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Yagita H; Ueno H
    Br J Ophthalmol; 2006 Dec; 90(12):1535-41. PubMed ID: 16914468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of VLA-4 in the development of allergic conjunctivitis in mice.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
    Mol Vis; 2006 Apr; 12():310-7. PubMed ID: 16617298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
    Fukushima A; Ishida W; Ojima A; Kajisako M; Sumi T; Yamada J; Tsuru E; Miyazaki J; Tominaga A; Yagita H
    Int Arch Allergy Immunol; 2010; 151(2):129-36. PubMed ID: 19752566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells participate in 4-1BB-mediated suppression of experimental allergic conjunctivitis.
    Sumi T; Ishida W; Mittler RS; Yagita H; Taguchi O; Fukushima A
    Int Arch Allergy Immunol; 2009; 148(4):305-10. PubMed ID: 19001790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B and T lymphocyte attenuator regulates the development of antigen-induced experimental conjunctivitis.
    Ishida W; Fukuda K; Kajisako M; Sumi T; Matsuda H; Yagita H; Fukushima A
    Graefes Arch Clin Exp Ophthalmol; 2012 Feb; 250(2):289-95. PubMed ID: 21779950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunization protocol determines whether endogenous interferon-gamma suppresses the infiltration of eosinophils into the conjunctiva.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ozaki A; Ueno H
    Immunol Lett; 2005 Sep; 100(2):189-94. PubMed ID: 15919119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice.
    Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Okumura K; Akiba H; Yagita H; Ueno H
    Int Arch Allergy Immunol; 2008; 146(1):36-43. PubMed ID: 18087160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of CD4+CD25+ T cells in the development of experimental murine allergic conjunctivitis.
    Fukushima A; Yamaguchi T; Sumi T; Fukuda K; Kumagai N; Nishida T; Takeuchi M; Taguchi O; Ueno H
    Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):705-14. PubMed ID: 17024440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Liu FT; Ueno H
    Clin Exp Ophthalmol; 2006; 34(4):347-53. PubMed ID: 16764655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis.
    Fukushima A; Sumi T; Ishida W; Yamada J; Iwakura Y; Ueno H
    Int Arch Allergy Immunol; 2008; 147(3):206-12. PubMed ID: 18594150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissection of antigen-specific humoral and cellular immune responses for the development of experimental immune-mediated blepharoconjunctivitis in C57BL/6 mice.
    Fukushima A; Ozaki A; Jian Z; Ishida W; Fukata K; Ueno H; Liu FT
    Curr Eye Res; 2005 Apr; 30(4):241-8. PubMed ID: 15823916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis.
    Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Ueno H
    Int Arch Allergy Immunol; 2007; 144(1):79-84. PubMed ID: 17505142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T cells play disparate roles in the induction and the effector phases of murine experimental allergic conjunctivitis.
    Fukushima A; Yamaguchi T; Fukuda K; Sumi T; Kumagai N; Nishida T; Imai S; Ueno H
    Microbiol Immunol; 2006; 50(9):719-28. PubMed ID: 16985294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
    Sumi T; Fukushima A; Nishino K; Fukuda K; Kumagai N; Nishida T; Ueno H
    Cell Biol Int; 2009 Apr; 33(4):534-41. PubMed ID: 19230848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of tumour-necrosis factor-related apoptosis-inducing ligand receptor enhances the severity of murine allergic conjunctivitis.
    Sumi T; Ishida W; Okumura K; Yagita H; Fukushima A
    Br J Ophthalmol; 2009 Jan; 93(1):110-5. PubMed ID: 18782797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction between ICOS and B7RP-1 is not required for the development of experimental murine allergic conjunctivitis.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1726-31. PubMed ID: 16289109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.